Bridgewater Associates LP Cuts Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Bridgewater Associates LP lowered its position in Addus HomeCare Co. (NASDAQ:ADUS) by 47.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,019 shares of the company’s stock after selling 7,167 shares during the quarter. Bridgewater Associates LP’s holdings in Addus HomeCare were worth $1,067,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of ADUS. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after buying an additional 88 shares during the period. Quest Partners LLC bought a new stake in Addus HomeCare in the 2nd quarter worth $31,000. Innealta Capital LLC purchased a new position in shares of Addus HomeCare in the second quarter valued at about $44,000. Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the last quarter. Finally, Sandia Investment Management LP bought a new stake in shares of Addus HomeCare in the second quarter worth about $58,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on ADUS shares. Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $136.00 price target on shares of Addus HomeCare in a research note on Thursday, November 14th. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective on the stock. Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, Macquarie restated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $122.84 on Monday. The company has a 50-day moving average of $127.30 and a 200 day moving average of $123.66. The firm has a market cap of $2.23 billion, a price-to-earnings ratio of 28.11, a PEG ratio of 2.15 and a beta of 1.04. Addus HomeCare Co. has a 1 year low of $85.43 and a 1 year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business earned $1.03 EPS. On average, equities analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current year.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the completion of the sale, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. This trade represents a 11.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,500 shares of company stock worth $1,668,265 in the last three months. 4.60% of the stock is owned by corporate insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.